The largest database of trusted experimental protocols

Anti cd11b apc

Manufactured by Miltenyi Biotec
Sourced in United States

Anti-CD11b-APC is a fluorescently-labeled antibody that binds to the CD11b (Integrin αM) cell surface antigen. CD11b is expressed on various immune cells, including monocytes, macrophages, and granulocytes. The APC (Allophycocyanin) fluorophore is conjugated to the antibody, enabling detection and analysis of CD11b-positive cells using flow cytometry.

Automatically generated - may contain errors

9 protocols using anti cd11b apc

1

Multiparametric Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cervical lymph node cells were isolated, washed, counted, and resuspended at 100,000 cells in 50 μL of flow cytometry buffer. Cells were treated with FcR-block (Miltenyi Biotec, Bergisch Gladbach, Germany) and labeled for surface markers via antibodies, per the manufacturer’s instructions31 (link),39 (link). Dead cells were excluded from analysis by labeling with propidium iodide viability dye (Miltenyi Biotec), per the manufacturer’s instructions31 (link),39 (link). Neutrophils: anti-CD11b-APC (Miltenyi Biotec; clone REA592), anti-Ly6C-FITC (Miltenyi Biotec; clone REA796), anti-Ly6G-VioBlue (Miltenyi Biotec; clone 1A8). M1-macrophages: anti-CD11b-APC (Miltenyi Biotec; clone REA592), anti-MHC II-FITC (Miltenyi Biotec; clone REA528), anti-CD206-PE (Miltenyi Biotec; clone MR6F3), anti-CD64-APC-Vio770 (Miltenyi Biotec; clone REA286). Plasmacytoid dendritic cells: anti-CD11c-PE-Vio770 (Miltenyi Biotec; clone REA754), anti-MHC II-FITC (Miltenyi Biotec; clone REA528), anti-B220-VioBlue (Miltenyi Biotec; clone REA755). A minimum of 5,000 gated cells were analyzed per specimen. Data was acquired by the MACSQuant System (Miltenyi Biotec) and analyses were performed via FlowJo 11.0 software (TreeStar, Ashland, OR, USA), as previously reported31 (link),39 (link).
+ Open protocol
+ Expand
2

Immune Cell Subset Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with FcR‐block (Miltenyi Biotec) and stained for cell surface markers. Myeloid‐derived suppressor cells (MDSCs): anti‐CD11b‐APC (Miltenyi Biotec; clone REA592), anti‐Ly6G‐VioBlue (Miltenyi Biotec; clone 1A8), anti‐F4/80‐PE (Miltenyi Biotec; clone REA126), anti‐Ly6C‐FITC (Miltenyi Biotec; clone REA796). Plasmacytoid dendritic cells (pDC): anti‐CD11c‐PE‐Vio770 (Miltenyi Biotec; clone REA754), anti‐MHC II‐FITC (Miltenyi Biotec; clone REA528), anti‐B220‐VioBlue (Miltenyi Biotec; clone REA755). M1/M2 macrophages: anti‐CD11b‐APC (Miltenyi Biotec; clone REA592), anti‐CD11c‐PE‐Vio770 (Miltenyi Biotec; clone REA754), anti‐MHC class II‐FITC (Miltenyi Biotec; clone REA528), anti‐CD64‐APC‐Vio770 (Miltenyi Biotec; clone REA286), anti‐B220‐VioBlue (Miltenyi Biotec; clone REA755), anti‐CD206‐PE (eBioscience, Santa Clara, CA, USA; clone MR6F3). Dead cells were excluded from analysis via propidium iodide viability dye (Miltenyi Biotec).
+ Open protocol
+ Expand
3

Immunophenotyping of Monocytes and Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples of 50 μL of whole blood were stained using an optimized cocktail including anti-CD14 PE and anti-human leucocyte antigen DR (HLADR) FITH (PARTEC, Germany), anti-CD33 PECy7.7 and anti-CD15 VB515 (BD, United States), and anti-CD11b-APC (Miltenyi, Germany). A Sysmex-Partec flow cytometry was used, cells were gated to single events, and CD14+ cells were selected from CD33-positive events (monocytes). After exclusion of CD33+ and CD15+ cells, lymphocytes were gated in a forward scatter–side scatter (FSC–SSC) dot plot. Both monocytes and lymphocytes were later analyzed for HLA-DR expression and mean fluorescence intensity (MFI) was recorded.
+ Open protocol
+ Expand
4

Detecting Mouse MDSC Subsets and TLR7

Check if the same lab product or an alternative is used in the 5 most similar protocols
To detect mouse MDSC subsets, cell suspensions isolated from the spleens and kidneys were first incubated with Fc-blockeranti-CD16/32 antibody (dilution 1:20, Miltenyi Biotech) for 15 min, stained and pre-incubated with anti-CD11b-APC (1 μl/test) and anti-GR-1-PE (0.3 μl/test) for 30 min at 4°C in the dark. Cells were then washed with buffer to remove the excess stains and analyzed in a FACS (Becton Dickinson, San Diego, CA, USA). To detect TLR7 of MDSCs in pristane-treated mice, after stained with anti-CD11b-APC and anti-GR-1-PE, fixed and permeabilized by BD Fixation/Permeabilization Solution Kit (BD Pharmingen, USA), stained with anti-TLR7-FITC (Invitrogen, USA) for 30 min at 4°C.
+ Open protocol
+ Expand
5

Isolation and Immunophenotyping of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mesenteric and liver (celiac, portal) lymph nodes cells were isolated, washed, and counted. Cells were treated with FcR-block (Miltenyi Biotec) and stains were performed. Inflammatory monocytes: anti-CD11b-APC (Miltenyi Biotec, clone M1/70.15.11.5), anti-Ly6g-PacB (Biolegend, clone 18A), anti-F4/80-PE (eBioscience, clone BM8), anti-Ly6c-FITC (Novus Biologicals, clone HK1.4). T-cell hematopoiesis: anti-CD3e-APC (Miltenyi Biotec, clone 145-2C11), anti-TCRγδ-e450 (eBioscience, clone eBioGL3), anti-CD8a-PE (Miltenyi Biotec, clone 53-6.7), anti-CD4-FITC (Miltenyi Biotec, clone GK1.5). Dead cells were excluded via propidium iodide viability dye (Miltenyi Biotec). Data was acquired by the MACSQuant System (Miltenyi Biotec). Analyses were performed via FlowJo VX software (TreeStar).
+ Open protocol
+ Expand
6

Isolation and Analysis of Microglia from TBI Mouse Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
To isolate microglia for WB analysis, TBI‐ or sham‐treated wild‐type mice were anesthetized, and the brain was dissected. Then the injured‐ or sham‐treated cortex was collected and digested using 0.25% trypsin. After being filtered with a 75 μm cell strainer, it was resuspended into 35% Percoll and centrifugated at 400 g to remove myelin as reported.
20 (link) Then cell pellets were resuspended in PBS and labeled with anti‐CD11b‐APC (Miltenyi, 1:50) and anti‐CD45‐FITC (BD, 1:100). CD11b and CD45 were used for distinguishing resident microglia (CD11b+, CD45low), activated microglia (CD11b+, CD45intermediate), and infiltrating macrophages (CD11b+, CD45high) as reported.
31 (link) Gates were established using antibody isotype controls and fluorescence minus‐one controls. Samples were acquired by Beckman MoFlo Astrios Cell Sorter and analyzed with Flowjo 10.0 software. Only CD11b+, CD45low, and CD11b+, CD45intermediate cells were acquired, which indicated the microglia in the cortex specifically. Samples were then denatured with an SDS‐PAGE loading buffer and subjected to WB detection.
+ Open protocol
+ Expand
7

Isolation and Labeling of Brain Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Detailed methods are provided in the online version of this paper and include the following: Resource dissociated by gentle trituration using a 1 mL pipette. Dissociated cells were layered on the top of 5 mL of Ovomucoid inhibitor solution (Worthington Biochemical Corp.) and harvested by centrifugation (140 x g for 6 min). This method routinely yielded $2 3 10 6 cells per mouse brain. Cell aggregates were removed by filtering with 30 mm cell strainers (Becton Dickinson). The cell suspension was then labeled for oligodendrocyte marker 1:50 anti-O4-PE (Miltenyi Biotec), endhothelial cell marker 1:50 anti-CD31-PE (Miltenyi Biotec) and microglial marker 1:50 anti-CD11b-APC (Miltenyi Biotec), according to the standard manufacturer's protocol. To collect astrocytes, GFAP/EGFP mice were used. The cells were kept on ice until sorting.
+ Open protocol
+ Expand
8

Isolation and Activation of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was drawn into sodium heparin tubes (APP Pharmaceuticals, NDC 63323-540-11). CD4+, CD8+, and CD14+ cells were isolated from whole blood using anti-CD4/CD8/CD14 microbeads (130-090-877/130-090-878/130-090-879, Miltenyi Biotec) and Automatics purification as per the manufacturer’s instructions. A small portion of the cell isolate was set aside for flow cytometry using anti-CD3 APC-H7, anti-CD4 PE-Cy7, anti-CD11b-APC, anti-CD8 PE, anti CD14 – FITC (Miltenyi Biotec) to assess the purity. All antibodies were purchased from BD Pharmingen unless otherwise indicated. Isolated cells were re-suspended at 1 million/ml in RPMI containing 10% FBS and either immediately lysed in 0.7 ml QIAzol lysis reagent (Qiagen) or incubated for 4 h at 37 °C with 25 μl/ml anti-CD3/antiCD28 Human T-Activator Dynabeads (111.32D, Invitrogen) for CD4 and CD8 cells or 1 μg/ml pI:C (528906, Calbiochem), LPS (L439, Sigma) CPG ODN2006, Invivogen) and PGN (Sigma, 77140) for CD14 cells. Lysates were stored at −80 °C until processing for RNAseq.
+ Open protocol
+ Expand
9

Saliva Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The saliva samples were diluted with phosphate-buffered saline (PBS) (1:10) and centrifuged at 1000 rcf for 10 min. The pellet obtained was then further subjected to antibody staining and flow cytometry analysis. Briefly, the cells were resuspended in PBS and labeled with anti-CD191-PE (1:100 dilution), anti-CD11b-APC (1:100 dilution), anti-CD192-APC (1:100 dilution), anti-CD185-PE (1:100 dilution), and anti-CD195-FITC (1:100 dilution) (Miltenyi Biotec, Bergisch Gladbach, Germany). After incubation for 30 min at room temperature, the cells were acquired on a flow cytometer (Attune NxT, Thermo Fisher Scientific, Waltham, MA, USA). A total of 5000 cell events were acquired in each sample. The median fluorescence intensities were calculated and compared.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!